![Bernard Daugeras](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bernard Daugeras
Fondatore presso
Auriga Partners SA
Profilo
Bernard Daugeras is the founder.
Dr. Daugeras is the founder of Auriga Partners SA, serving as Chairman of the Board since 2010, founded in 1998.
Dr. Daugeras is also the founder of RDS SAS. Dr. Daugeras is currently a Non-Executive Director at Domain Therapeutics SA since 2008, a Director at Isocell Nutra SAS, a Director at Prophesee SA, a Director at IHU Strasbourg, and a Member of the Supervisory Board at Firalis SA. Former positions include Chairman at Sangamo Therapeutics France SAS from 2012 to 2013, Director at Nicox SA, Director at Novagali Pharma SA, Director at MEDIAN Technologies SA, Director at Population Genetics Technologies Ltd., Director at Theranexus SA, Principal at Crédit Lyonnais SA in 1990, Member of the Supervisory Board at Valerio Therapeutics SA, Principal at the University of California, Berkeley, Member of the Supervisory Board at Nemoptic SA, Member of the Supervisory Board at INSERM Transfert SA, Researcher at the University of Orsay, Member of the Supervisory Board at SuperSonic Imagine SA from 2005 to 2015, Principal at Finovelec, Member at Académie des Technologies, and Principal at Centre National de la Recherche Scientifique.
Education includes a doctorate from the University of Orsay and an undergraduate degree from Ecole Polytechnique.
Posizioni attive di Bernard Daugeras
| Società | Posizione | Inizio |
|---|---|---|
Auriga Partners SA
 Auriga Partners SA Investment ManagersFinance Auriga Partners invests in small and mid sized companies located in France and Europe. The firm targets companies operating in the fields of IT and life science sectors. It provides financing for seed and early stage capital requirements with an investment size ranging between EUR 1 - 5 million and also take minority stakes. | Fondatore | 12/06/1998 |
Domain Therapeutics SA
 Domain Therapeutics SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that manufacture immuno-oncology and inflammation products | Direttore/Membro del Consiglio | 01/01/2008 |
Isocell SA
 Isocell SA Food RetailRetail Trade Perates as a holding company with interests in the manufacture and sale of food supplements | Direttore/Membro del Consiglio | - |
Firalis SA
 Firalis SA BiotechnologyHealth Technology Engages in the discovery and development of biomarker-based diagnostics | Direttore/Membro del Consiglio | - |
IHU Strasbourg
 IHU Strasbourg Hospital/Nursing ManagementHealth Services Provides medical and surgical center services | Direttore/Membro del Consiglio | - |
Prophesee SA
 Prophesee SA Medical SpecialtiesHealth Technology Develops vision sensors and systems | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Bernard Daugeras
| Società | Posizione | Fine |
|---|---|---|
| SUPERSONIC IMAGINE | Direttore/Membro del Consiglio | 26/02/2015 |
Crédit Lyonnais SA
 Crédit Lyonnais SA Major BanksFinance Provides banking services | Corporate Officer/Principal | 01/01/1990 |
INSERM Transfert SA
 INSERM Transfert SA Investment ManagersFinance ITSA is an active private equity investment manager focused exclusively on the French biomedical sector, particularly on areas related to INSERM's medical research effort. They favor projects in fields including therapeutic agents, medical devices, diagnostics, tools and technological platforms. The firm invests between EUR 100 and 300 thousand in pre-seed and seed financing. ITSA's investment criteria include sound science, a driven management team, strong IP, a realistic business model with a clearly defined market, and a competitive milestone-driven schedule. They seek to invest in ambitious projects addressing unmet medical needs and potentially leading to dominant market positions. The firm may act as a co-founder, generally sits on the board of their portfolio companies and actively participates in their strategic decisions. | Direttore/Membro del Consiglio | - |
| ░░░ ░░░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
Formazione di Bernard Daugeras
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
62
Relazioni di 1° grado
24
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 24 |
|---|---|
Crédit Lyonnais SA
Crédit Lyonnais SA Major BanksFinance Provides banking services | Finance |
Nicox SA
 Nicox SA Pharmaceuticals: MajorHealth Technology Manufactures and sells ophthalmology biopharmaceuticals | Health Technology |
Auriga Partners SA
Auriga Partners SA Investment ManagersFinance Auriga Partners invests in small and mid sized companies located in France and Europe. The firm targets companies operating in the fields of IT and life science sectors. It provides financing for seed and early stage capital requirements with an investment size ranging between EUR 1 - 5 million and also take minority stakes. | Finance |
Valerio Therapeutics SA
 Valerio Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Domain Therapeutics SA
Domain Therapeutics SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that manufacture immuno-oncology and inflammation products | Health Technology |
Novagali Pharma SA
 Novagali Pharma SA Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for eye treatment | Health Technology |
MEDIAN Technologies SA
 MEDIAN Technologies SA Medical/Nursing ServicesHealth Services Engages in the development and market of software publishing solutions and provision of services in the field of medical imaging in oncology | Health Services |
Nemoptic SA
 Nemoptic SA Electronic Production EquipmentElectronic Technology Designs and manufactures liquid crystal displays (LCD) for consumer and professional mobile devices | Electronic Technology |
INSERM Transfert SA
INSERM Transfert SA Investment ManagersFinance ITSA is an active private equity investment manager focused exclusively on the French biomedical sector, particularly on areas related to INSERM's medical research effort. They favor projects in fields including therapeutic agents, medical devices, diagnostics, tools and technological platforms. The firm invests between EUR 100 and 300 thousand in pre-seed and seed financing. ITSA's investment criteria include sound science, a driven management team, strong IP, a realistic business model with a clearly defined market, and a competitive milestone-driven schedule. They seek to invest in ambitious projects addressing unmet medical needs and potentially leading to dominant market positions. The firm may act as a co-founder, generally sits on the board of their portfolio companies and actively participates in their strategic decisions. | Finance |
University of Orsay
 University of Orsay Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SuperSonic Imagine SA
 SuperSonic Imagine SA Medical SpecialtiesHealth Technology Develops and manufactures ultrasound systems & medical imaging devices | Health Technology |
Ecole Polytechnique
 Ecole Polytechnique Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Finovelec | |
Académie des Technologies
 Académie des Technologies Academie des Technologies engages in the technology industry. The company was founded in December 2000 and is headquartered in Paris, France. | |
Sangamo Therapeutics France SAS
 Sangamo Therapeutics France SAS BiotechnologyHealth Technology Develops cellular immunotherapy platforms that treats severe inflammatory and autoimmune diseases | Health Technology |
Population Genetics Technologies Ltd.
 Population Genetics Technologies Ltd. Miscellaneous Commercial ServicesCommercial Services Offers population genetics studies | Commercial Services |
Centre National de la Recherche Scientifique
 Centre National de la Recherche Scientifique General GovernmentGovernment Provides scientific research services | Government |
Isocell SA
Isocell SA Food RetailRetail Trade Perates as a holding company with interests in the manufacture and sale of food supplements | Retail Trade |
Firalis SA
Firalis SA BiotechnologyHealth Technology Engages in the discovery and development of biomarker-based diagnostics | Health Technology |
Theranexus SA
 Theranexus SA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for treatment of central nervous system diseases | Health Technology |
Prophesee SA
Prophesee SA Medical SpecialtiesHealth Technology Develops vision sensors and systems | Health Technology |
IHU Strasbourg
IHU Strasbourg Hospital/Nursing ManagementHealth Services Provides medical and surgical center services | Health Services |
Rds SAS
 Rds SAS Packaged SoftwareTechnology Services Provides real-time monitoring solutions for healthcare industry | Technology Services |
